Captrust Financial Advisors Grows Stock Position in Keurig Dr Pepper Inc. (NASDAQ:KDP)

Captrust Financial Advisors increased its holdings in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) by 26.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 69,463 shares of the company's stock after buying an additional 14,522 shares during the quarter. Captrust Financial Advisors' holdings in Keurig Dr Pepper were worth $2,231,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Keurig Dr Pepper by 23.6% during the 4th quarter. Vanguard Group Inc. now owns 119,587,162 shares of the company's stock valued at $3,841,140,000 after buying an additional 22,856,757 shares during the period. Wellington Management Group LLP grew its stake in Keurig Dr Pepper by 10.3% during the 4th quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company's stock valued at $1,946,561,000 after purchasing an additional 5,646,179 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in Keurig Dr Pepper by 36.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company's stock valued at $1,755,564,000 after purchasing an additional 14,473,054 shares in the last quarter. Geode Capital Management LLC grew its stake in Keurig Dr Pepper by 8.7% during the 4th quarter. Geode Capital Management LLC now owns 24,511,039 shares of the company's stock valued at $784,974,000 after purchasing an additional 1,962,195 shares in the last quarter. Finally, Invesco Ltd. grew its stake in Keurig Dr Pepper by 19.6% during the 4th quarter. Invesco Ltd. now owns 21,605,610 shares of the company's stock valued at $693,972,000 after purchasing an additional 3,539,463 shares in the last quarter. 93.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Keurig Dr Pepper

In other news, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $34.11, for a total value of $409,320.00. Following the completion of the transaction, the insider now directly owns 142,511 shares of the company's stock, valued at approximately $4,861,050.21. This represents a 7.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Angela A. Stephens sold 14,500 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $34.24, for a total value of $496,480.00. Following the completion of the transaction, the vice president now directly owns 62,411 shares of the company's stock, valued at approximately $2,136,952.64. The trade was a 18.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 84,863,850 shares of company stock valued at $2,772,203,450 in the last 90 days. 0.40% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

KDP has been the subject of several research reports. Morgan Stanley upgraded Keurig Dr Pepper from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $38.00 to $40.00 in a research report on Tuesday, April 1st. Argus initiated coverage on Keurig Dr Pepper in a research report on Wednesday, April 16th. They issued a "buy" rating and a $40.00 target price for the company. Wells Fargo & Company restated an "overweight" rating on shares of Keurig Dr Pepper in a research report on Tuesday, February 25th. JPMorgan Chase & Co. boosted their price objective on Keurig Dr Pepper from $37.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Finally, UBS Group boosted their price objective on Keurig Dr Pepper from $40.00 to $42.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. Four equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $39.33.

Keurig Dr Pepper Stock Performance

KDP opened at $33.51 on Tuesday. The company has a market cap of $45.51 billion, a PE ratio of 20.31, a price-to-earnings-growth ratio of 2.42 and a beta of 0.52. The stock has a 50-day moving average of $34.21 and a 200-day moving average of $33.01. Keurig Dr Pepper Inc. has a 52-week low of $30.12 and a 52-week high of $38.28. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.36 and a current ratio of 0.53.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.04. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The company had revenue of $3.64 billion during the quarter, compared to the consensus estimate of $3.57 billion. During the same quarter in the prior year, the company posted $0.38 EPS. The firm's revenue was up 4.8% on a year-over-year basis. As a group, equities research analysts forecast that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current fiscal year.

Keurig Dr Pepper Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.